Should we take another look at antenatal corticosteroids? March 08, 2017By Debra A. Guinn MDThe risks of administering ACS at late term and term remain unknown, says this MFM specialist.
In this issue
Bilateral salpingectomy: An opportunity to reduce cancer riskThe data, say the authors, support counseling post-reproductive women undergoing hysterectomy about the risks and benefits of retaining their fallopian tubes. Medical marijuana: An oxymoron and a risk to fetusesIt's never appropriate in pregnancy, says our editor in chief. Trimester zero (Part 1 of 2)Preconception care is primary prevention. The goal is to affirm pregnancy intention, reduce any potential harm, and recognize modifiable risk factors related to pregnancy while stratifying pregnancies on a continuum of low- to high-risk. Readers React: In defense of breast density notification lawsWe read with interest the article “Breast density laws: Are you in compliance?” [December 2016 Contemporary OB/GYN]. We appreciated the perspective of our gynecologist colleagues. We would like to help clarify and give context to some of the information in the article. Readers react
March 01, 2017Readers write in about their thoughts on the annual labor force survey, the conundrum presented by cesarean delivery and defensive medicine, more information on treating women who have been the victim of sexual assault, and what is adding to the stress of the job.
SMFM Consult: Ultrasound in the cfDNA era
March 15, 2017The society's recommendations for women who are undergoing both ultrasound and cfDNA screening.